Context will also participate in one-on-one meetings at each of the above conferences.

Agenus Inc. , a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that ...

According to a recent study by the Centers for Disease Control and Prevention (CDC), three out of 150 veterinarians working ...

Entered into an additional clinical study collaboration and supply agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with Trodelvy, Gilead's Trop-2 directed ADC, in ...

A video of Robert F. Kennedy Jr. in his Senate confirmation hearing repeating a misleading narrative that Black people should ...

Guselkumab targets the p19 alpha subunit of IL-23. While IL-23 promotes normal inflammatory and immune responses, the p19 and ...

It takes some time to fully understand how different allergies, intolerances, or autoimmune problems affect different people, ...

Early signs of whooping cough in adults look very much like a common cold, Dr. Loafman says. For the first week or so of ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

With Robert F Kennedy Jr confirmed as the new health secretary under President Donald Trump, the food tech sector faces a ...

Biodegradable net wrap, neonatal supplements and lidocaine-infused castration bands are just some of the products researchers ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...